MDGL

SEC source: 0001628280-25-009091 · wk-form4_1740778579.xml · derivative · entry 2

Sibold William John · CIK 0001518611 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 50,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: On September 11, 2023, the Reporting Person was granted a one-time sign-on award of performance-based restricted stock units (PSUs) with a target award of 50,000 shares of common stock that can be earned upon the achievement of significant sustained stock price appreciation hurdles over a five-year period. The Reporting Person can earn up to 300% of the target award and is eligible to earn up to an additional 100,000 shares upon the achievement of sustained stock price appreciation hurdles. See the Issuer's Schedule 14A filed with the Securities and Exchange Commission on April 29, 2024 for additional information about the PSUs.

F2 · price: On September 11, 2023, the Reporting Person was granted a one-time sign-on award of performance-based restricted stock units (PSUs) with a target award of 50,000 shares of common stock that can be earned upon the achievement of significant sustained stock price appreciation hurdles over a five-year period. The Reporting Person can earn up to 300% of the target award and is eligible to earn up to an additional 100,000 shares upon the achievement of sustained stock price appreciation hurdles. See the Issuer's Schedule 14A filed with the Securities and Exchange Commission on April 29, 2024 for additional information about the PSUs.

F2 · derivative.exercise_date: On September 11, 2023, the Reporting Person was granted a one-time sign-on award of performance-based restricted stock units (PSUs) with a target award of 50,000 shares of common stock that can be earned upon the achievement of significant sustained stock price appreciation hurdles over a five-year period. The Reporting Person can earn up to 300% of the target award and is eligible to earn up to an additional 100,000 shares upon the achievement of sustained stock price appreciation hurdles. See the Issuer's Schedule 14A filed with the Securities and Exchange Commission on April 29, 2024 for additional information about the PSUs.

F2 · derivative.expiration_date: On September 11, 2023, the Reporting Person was granted a one-time sign-on award of performance-based restricted stock units (PSUs) with a target award of 50,000 shares of common stock that can be earned upon the achievement of significant sustained stock price appreciation hurdles over a five-year period. The Reporting Person can earn up to 300% of the target award and is eligible to earn up to an additional 100,000 shares upon the achievement of sustained stock price appreciation hurdles. See the Issuer's Schedule 14A filed with the Securities and Exchange Commission on April 29, 2024 for additional information about the PSUs.

F2 · balance_after: On September 11, 2023, the Reporting Person was granted a one-time sign-on award of performance-based restricted stock units (PSUs) with a target award of 50,000 shares of common stock that can be earned upon the achievement of significant sustained stock price appreciation hurdles over a five-year period. The Reporting Person can earn up to 300% of the target award and is eligible to earn up to an additional 100,000 shares upon the achievement of sustained stock price appreciation hurdles. See the Issuer's Schedule 14A filed with the Securities and Exchange Commission on April 29, 2024 for additional information about the PSUs.

SEC source: 0001628280-25-009091 · wk-form4_1740778579.xml · nonDerivative · entry 1

Sibold William John · CIK 0001518611 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 104,303

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On February 27, 2025, the Reporting Person earned 50,000 shares of common stock following the achievement of the performance and service conditions of the Performance Restricted Stock Units described in Footnote 2. Although the Issuer is irrevocably obligated to issue these shares to the Reporting Person, these shares will settle and be delivered to the Reporting Person on September 8, 2027, the fourth anniversary of the commencement of his employment with the Issuer.

SEC source: 0001628280-25-009079 · wk-form4_1740778263.xml · derivative · entry 7

Daly James M · CIK 0001560782 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,000 shares

Expires 2025-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable.

SEC source: 0001628280-25-009079 · wk-form4_1740778263.xml · derivative · entry 6

Daly James M · CIK 0001560782 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,470 shares

Expires 2025-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable.

SEC source: 0001628280-25-009079 · wk-form4_1740778263.xml · nonDerivative · entry 5

Daly James M · CIK 0001560782 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,912

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $348.73 to $349.705, inclusive.

SEC source: 0001628280-25-009079 · wk-form4_1740778263.xml · nonDerivative · entry 4

Daly James M · CIK 0001560782 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,682

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $347.36 to $348.225, inclusive.

SEC source: 0001628280-25-009079 · wk-form4_1740778263.xml · nonDerivative · entry 3

Daly James M · CIK 0001560782 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,984

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $346.34 to $347.18, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.

SEC source: 0001628280-25-009079 · wk-form4_1740778263.xml · nonDerivative · entry 2

Daly James M · CIK 0001560782 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,382

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-25-009079 · wk-form4_1740778263.xml · nonDerivative · entry 1

Daly James M · CIK 0001560782 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,382

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-25-009076 · wk-form4_1740778208.xml · derivative · entry 15

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,470

Underlying: Common Stock · 4,530 shares

Expires 2026-07-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable.

SEC source: 0001628280-25-009076 · wk-form4_1740778208.xml · derivative · entry 14

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,470 shares

Expires 2025-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable.

SEC source: 0001628280-25-009076 · wk-form4_1740778208.xml · derivative · entry 13

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,000 shares

Expires 2025-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable.

SEC source: 0001628280-25-009076 · wk-form4_1740778208.xml · nonDerivative · entry 12

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,912

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $359.99 to $360.17, inclusive.

SEC source: 0001628280-25-009076 · wk-form4_1740778208.xml · nonDerivative · entry 11

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,128

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $358.94 to $359.84, inclusive.

SEC source: 0001628280-25-009076 · wk-form4_1740778208.xml · nonDerivative · entry 10

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,152

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $357.91 to $358.83, inclusive.

SEC source: 0001628280-25-009076 · wk-form4_1740778208.xml · nonDerivative · entry 9

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,700

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $356.83 to $357.79, inclusive.

SEC source: 0001628280-25-009076 · wk-form4_1740778208.xml · nonDerivative · entry 8

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,738

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $355.83 to $356.79, inclusive.

SEC source: 0001628280-25-009076 · wk-form4_1740778208.xml · nonDerivative · entry 7

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,529

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $354.79 to $355.78, inclusive.

SEC source: 0001628280-25-009076 · wk-form4_1740778208.xml · nonDerivative · entry 6

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,074

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.78 to $354.50, inclusive.

SEC source: 0001628280-25-009076 · wk-form4_1740778208.xml · nonDerivative · entry 5

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,312

SEC source: 0001628280-25-009076 · wk-form4_1740778208.xml · nonDerivative · entry 4

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,812

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.98 to $351.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.

SEC source: 0001628280-25-009076 · wk-form4_1740778208.xml · nonDerivative · entry 3

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,912

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-25-009076 · wk-form4_1740778208.xml · nonDerivative · entry 2

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,382

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-25-009076 · wk-form4_1740778208.xml · nonDerivative · entry 1

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,912

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-25-002680 · wk-form4_1738016309.xml · nonDerivative · entry 1

Huntsman Carole · CIK 0002001571 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,438

F1 · kind: The sale reported on this Form 4 represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.

SEC source: 0001628280-25-002655 · wk-form4_1738015378.xml · nonDerivative · entry 1

Waltermire Robert E. · CIK 0001876996 · Senior VP, Chief Pharma Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,955

F1 · kind: The sale reported on this Form 4 represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.

SEC source: 0001628280-25-002658 · wk-form4_1738015664.xml · nonDerivative · entry 1

Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 456,662

F1 · kind: The sale reported on this Form 4 represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.

SEC source: 0001628280-25-002666 · wk-form4_1738015934.xml · nonDerivative · entry 1

Sibold William John · CIK 0001518611 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,303

F1 · kind: The sale reported on this Form 4 represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.

SEC source: 0001628280-25-001902 · wk-form4_1737159023.xml · nonDerivative · entry 1

Kelley Shannon T · CIK 0002034056 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,705

F1 · kind: The sale reported on this Form 4 represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.

SEC source: 0001628280-25-001900 · wk-form4_1737158894.xml · nonDerivative · entry 1

Waltermire Robert E. · CIK 0001876996 · Senior VP, Chief Pharma Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,058

F1 · kind: The sale reported on this Form 4 represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.

SEC source: 0001628280-25-001898 · wk-form4_1737158698.xml · nonDerivative · entry 1

Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 457,310

F1 · kind: The sale reported on this Form 4 represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.

SEC source: 0001628280-24-050094 · wk-form4_1733435199.xml · nonDerivative · entry 2

CRAVES FRED B · CIK 0001014095 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 11,000

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $315.84 to $316.16, inclusive.

F2 · ownership.nature: Represents shares held indirectly by Dr. Craves through the Craves Family Foundation.

SEC source: 0001628280-24-050094 · wk-form4_1733435199.xml · nonDerivative · entry 1

CRAVES FRED B · CIK 0001014095 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 11,520

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $315.00 to $315.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.

F2 · ownership.nature: Represents shares held indirectly by Dr. Craves through the Craves Family Foundation.

SEC source: 0001628280-24-049400 · wk-form4_1732742168.xml · nonDerivative · entry 2

CRAVES FRED B · CIK 0001014095 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 14,600

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.46 to $351.06, inclusive.

F2 · ownership.nature: Represents shares held indirectly by Dr. Craves through the Craves Family Foundation.

SEC source: 0001628280-24-049400 · wk-form4_1732742168.xml · nonDerivative · entry 1

CRAVES FRED B · CIK 0001014095 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 15,800

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.00 to $350.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.

F2 · ownership.nature: Represents shares held indirectly by Dr. Craves through the Craves Family Foundation.

SEC source: 0000950170-24-130239 · ownership.xml · nonDerivative · entry 1

Huntsman Carole · CIK 0002001571 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,785

F1 · kind: The sale reported on this Form 4 represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.

SEC source: 0000950170-24-124232 · ownership.xml · derivative · entry 3

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2026-08-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable.

SEC source: 0000950170-24-124232 · ownership.xml · nonDerivative · entry 2

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,012

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023.

SEC source: 0000950170-24-124232 · ownership.xml · nonDerivative · entry 1

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,012

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000950170-24-121722 · ownership.xml · derivative · entry 6

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 5,000 shares

Expires 2026-08-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable.

SEC source: 0000950170-24-121722 · ownership.xml · nonDerivative · entry 5

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,012

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $303.99 to $304.55, inclusive.

SEC source: 0000950170-24-121722 · ownership.xml · nonDerivative · entry 4

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,312

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $302.11 to $302.30, inclusive.

SEC source: 0000950170-24-121722 · ownership.xml · nonDerivative · entry 3

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,112

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $301.00 to $301.76, inclusive.

SEC source: 0000950170-24-121722 · ownership.xml · nonDerivative · entry 2

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,212

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $300.00 to $300.44, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.

SEC source: 0000950170-24-121722 · ownership.xml · nonDerivative · entry 1

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,012

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000950170-24-107561 · ownership.xml · nonDerivative · entry 1

CRAVES FRED B · CIK 0001014095 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 360,076

SEC source: 0000950170-24-105650 · ownership.xml · nonDerivative · entry 1

Sibold William John · CIK 0001518611 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,887

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

SEC source: 0000950170-24-098804 · ownership.xml · derivative · entry 2

Kelley Shannon T · CIK 0002034056 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,820

Underlying: Common Stock · 7,820 shares

Expires 2034-08-15

F2 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (August 15, 2025) and, thereafter, 6.25% of the shares shall vest on each quarterly anniversary following the first anniversary, provided the Reporting Person continues in service with the Issuer on each such date.

SEC source: 0000950170-24-098804 · ownership.xml · nonDerivative · entry 1

Kelley Shannon T · CIK 0002034056 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,982

F1 · shares: Represents restricted stock units, which vest as to 25% of the shares on each of August 15, 2025, August 15, 2026, August 15, 2027 and August 15, 2028, provided the Reporting Person continues in service with the Issuer on each such date.

SEC source: 0000950170-24-078756 · ownership.xml · derivative · entry 5

CRAVES FRED B · CIK 0001014095 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,105

Underlying: Common Stock · 1,105 shares

Expires 2031-06-25

F5 · derivative.exercise_date: The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date.